| Year |
Citation |
Score |
| 2014 |
Morlacchi P, Robertson FM, Klostergaard J, McMurray JS. Targeting SH2 domains in breast cancer. Future Medicinal Chemistry. 6: 1909-26. PMID 25495984 DOI: 10.4155/Fmc.14.120 |
0.359 |
|
| 2014 |
Bertucci F, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, Van Dam P, Woodward WA, Cristofanilli M, Reuben JM, Dirix L, et al. Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 358-65. PMID 24299959 DOI: 10.1093/Annonc/Mdt496 |
0.354 |
|
| 2014 |
Fernandez SV, Robertson FM, Addya S, Mu Z, Cristofanilli M. Abstract 4988: Clues for targeted therapies in inflammatory breast cancer (IBC) Cancer Research. 74: 4988-4988. DOI: 10.1158/1538-7445.Am2014-4988 |
0.43 |
|
| 2013 |
Robertson FM, Chu K, Boley KM, Ye Z, Liu H, Wright MC, Moraes R, Zhang X, Green TL, Barsky SH, Heise C, Cristofanilli M. The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis. Journal of Experimental Therapeutics & Oncology. 10: 219-33. PMID 24416998 |
0.366 |
|
| 2013 |
Robertson FM, Petricoin Iii EF, Van Laere SJ, Bertucci F, Chu K, Fernandez SV, Mu Z, Alpaugh K, Pei J, Circo R, Wulfkuhle J, Ye Z, Boley KM, Liu H, Moraes R, et al. Presence of anaplastic lymphoma kinase in inflammatory breast cancer. Springerplus. 2: 497. PMID 24102046 DOI: 10.1186/2193-1801-2-497 |
0.408 |
|
| 2013 |
Fernandez SV, Robertson FM, Pei J, Aburto-Chumpitaz L, Mu Z, Chu K, Alpaugh RK, Huang Y, Cao Y, Ye Z, Cai KQ, Boley KM, Klein-Szanto AJ, Devarajan K, Addya S, et al. Inflammatory breast cancer (IBC): clues for targeted therapies. Breast Cancer Research and Treatment. 140: 23-33. PMID 23784380 DOI: 10.1007/S10549-013-2600-4 |
0.398 |
|
| 2013 |
Zhang EY, Cristofanilli M, Robertson F, Reuben JM, Mu Z, Beavis RC, Im H, Snyder M, Hofree M, Ideker T, Omenn GS, Fanayan S, Jeong SK, Paik YK, Zhang AF, et al. Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer. Journal of Proteome Research. 12: 2805-17. PMID 23647160 DOI: 10.1021/Pr4001527 |
0.323 |
|
| 2013 |
Chu K, Boley KM, Moraes R, Barsky SH, Robertson FM. The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism. Oncotarget. 4: 446-62. PMID 23530113 DOI: 10.18632/Oncotarget.872 |
0.416 |
|
| 2013 |
Van Laere SJ, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, van Dam P, Woodward WA, Viens P, Cristofanilli M, Birnbaum D, et al. Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4685-96. PMID 23396049 DOI: 10.1158/1078-0432.Ccr-12-2549 |
0.381 |
|
| 2013 |
Chu K, Green T, Boley K, Cristofanilli M, Robertson F. Abstract P6-12-14: Histone deacetylase inhibitor suberoylanilide hydroxamic acid targets breast cancer stem cells and inhibits metastasis Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P6-12-14 |
0.43 |
|
| 2013 |
Mu Z, Brown M, Fernandez S, Robertson F, Cristofanilli M. Abstract P3-01-05: Metabolomic analysis of breast cancer cell lines: Clues to the metabolic fingerprint of inflammatory breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P3-01-05 |
0.365 |
|
| 2013 |
Laere SV, Marsan M, Vermeulen P, Viens P, Barsky S, Cristofanilli M, Dirix L, Bertucci F, Robertson F. Abstract P2-05-04: Comparative expression profiling of patient samples and preclinical models of inflammatory breast cancer reveals gene signatures of epithelial plasticity and suppression of TGFb signaling Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-05-04 |
0.398 |
|
| 2012 |
Debeb BG, Cohen EN, Boley K, Freiter EM, Li L, Robertson FM, Reuben JM, Cristofanilli M, Buchholz TA, Woodward WA. Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast Cancer Research and Treatment. 134: 495-510. PMID 22547109 DOI: 10.1007/S10549-012-2075-8 |
0.387 |
|
| 2012 |
Fernandez SV, Mu Z, Aburto L, Dong X, Chu K, Boley K, Berditchevski F, Robertson F, Cristofanilli M. Abstract 5342: FC-IBC-02: A newin vitro-in vivomodel of inflammatory breast cancer (IBC) Cancer Research. 72: 5342-5342. DOI: 10.1158/1538-7445.Am2012-5342 |
0.418 |
|
| 2012 |
Liu H, Chu K, Ochoa A, Ye Z, Zhang X, Jin J, Wright M, Barsky S, Cristofanilli M, Robertson F. Abstract P6-10-04: The Presence of Anaplastic Lymphoma Kinase Recapitulates Formation of Breast Tumor Emboli with Encircling Lymphovasculogenesis Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P6-10-04 |
0.447 |
|
| 2012 |
Chu K, Boley K, Cristofanilli M, Robertson F. Abstract P5-04-05: E-Cadherin is Required for In Vivo Growth of Inflammatory Breast Cancer: Importance of Mesenchymal-Epithelial Transition (MET) and Role of HIF1α Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P5-04-05 |
0.416 |
|
| 2012 |
Robertson F, Hibbs S, Boley K, Chu K, Ye Z, Wright M, Liu H, Luo A, Cristofanilli M, Wemhoff G. Abstract P4-06-03: Zinc Finger Nuclease Genome Engineering Reveal Multiple Functions of Secretory Leukocyte Peptidase Inhibitor in Regulating Pleuripotency of Cancer Stem Cells in Inflammatory Breast Cancer Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P4-06-03 |
0.455 |
|
| 2012 |
Robertson FM, Cristofanilli M. New therapeutic targets in inflammatory breast cancer Current Breast Cancer Reports. 4: 264-270. DOI: 10.1007/S12609-012-0087-3 |
0.34 |
|
| 2012 |
Robertson FM, Chu K, Circo R, Wulfkuhle J, Liotta L, Luo AZ, Boley KM, Freiter EM, Liu H, Mandal PK, Mc Murray JS, Cristofanilli M, Petricoin EF. Inflammatory mediators as therapeutic targets for inflammatory breast cancer Inflammatory Breast Cancer: An Update. 185-205. DOI: 10.1007/978-94-007-3907-9_16 |
0.319 |
|
| 2011 |
Van Laere SJ, Ueno NT, Finetti P, Vermeulen PB, Lucci A, Birnbaum D, Robertson F, Iwamoto T, van Dam PA, Woodward WA, Viens P, Dirix LY, Reuben JM, Bertucci F. An integrated analysis of three distinct IBC/non-IBC affymetrix gene expression data sets to study the transcriptional heterogeneity both between IBC and non-IBC and within IBC. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10571. PMID 28021912 DOI: 10.1200/Jco.2011.29.15_Suppl.10571 |
0.353 |
|
| 2011 |
Mandal PK, Freiter EM, Bagsby AL, Robertson FM, McMurray JS. Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells. Bioorganic & Medicinal Chemistry Letters. 21: 6071-3. PMID 21903394 DOI: 10.1016/J.Bmcl.2011.08.050 |
0.359 |
|
| 2011 |
Robertson FM, Cristofanilli M. A global approach to inflammatory breast cancer. Future Oncology (London, England). 7: 25-30. PMID 21174535 DOI: 10.2217/Fon.10.177 |
0.339 |
|
| 2011 |
Iwamoto T, Bianchini G, Qi Y, Cristofanilli M, Lucci A, Woodward WA, Reuben JM, Matsuoka J, Gong Y, Krishnamurthy S, Valero V, Hortobagyi GN, Robertson F, Symmans WF, Pusztai L, et al. Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer Breast Cancer Research and Treatment. 125: 785-795. PMID 21153052 DOI: 10.1007/S10549-010-1280-6 |
0.383 |
|
| 2011 |
Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 22: 515-23. PMID 20603440 DOI: 10.1093/Annonc/Mdq345 |
0.368 |
|
| 2011 |
Debeb BG, Lacerda L, Xu W, Robertson F, Ueno NT, Lucci A, Reuben JM, Buchholz TA, Woodward WA. Abstract 3340: Expansion of human breast cancer stem /progenitor cell subpopulation through histone deacetylase inhibitors Cancer Research. 71: 3340-3340. DOI: 10.1158/1538-7445.Am2011-3340 |
0.354 |
|
| 2011 |
Laere SJV, Ueno N, Finetti P, Vermeulen PB, Lucci A, Birnbaum D, Robertson F, Iwamoto T, Dam PV, Woodward W, Viens P, Dirix LY, Reuben JR, Bertucci F. Abstract 328: An integrated analysis of three distinct IBC/non-IBC Affymetrix gene expression data sets to study the transcriptional heterogeneity both between IBC and non-IBC and within IBC Cancer Research. 71: 328-328. DOI: 10.1158/1538-7445.Am2011-328 |
0.324 |
|
| 2011 |
Robertson FM. Abstract PR-4: Gene amplification of anaplastic lymphoma kinase in inflammatory breast cancer. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-Pr-4 |
0.424 |
|
| 2011 |
McMurray JS, Klostergaard J, Robertson FM, Mandal PK, Auzenne EJ, Liao WS. Abstract B8: Selective inhibition of Stat3 Tyr705 phosphorylation inhibits angiogenesis in breast cancer xenografts. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B8 |
0.365 |
|
| 2011 |
Laere SV, Ueno N, Finetti P, Vermeulen P, Lucci A, Birnbaum D, Robertson F, Dam Pv, Woodward W, Viens P, Dirix L, Reuben J, Iwamoto T, Cristofanilli M, Bertucci F. PD03-01: An Integrated Analysis of Three Distinct IBC/nIBC Affymetrix Gene Expression Data Sets Further Unveils the Molecular Biology of IBC. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-Pd03-01 |
0.335 |
|
| 2011 |
Robertson F, Ye Z, Chu K, Luo A, Wright M, Jin J, Barsky S, Cristofanilli M, Krishnamurthy S. P4-09-08: Secretory Leukocyte Protease Inhibitor as a Differential Diagnostic Biomarker of Tumor Emboli in Inflammatory Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P4-09-08 |
0.441 |
|
| 2011 |
Chu K, Mu Z, Alpaugh K, Fernandez S, Freiter E, Wu H, Zook M, Barsky S, Cristofanilli M, Robertson F. P4-03-06: Development and Comparative Characterization of Metastasis in Newly Developed Pre-Clinical Models of Inflammatory Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P4-03-06 |
0.422 |
|
| 2011 |
Liu H, Luo A, Mu Z, Chu K, Ye Z, Alpaugh R, Fernandez S, Boley K, Jin J, Wright M, Cristofanilli M, Robertson F. P2-05-04: Mapping the Specific Gene Families Activated in the Lymphangiogenesis and Vasculogenic Mimicry Exhibited by Inflammatory Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-05-04 |
0.432 |
|
| 2011 |
Chu K, Boley K, Luo A, Ye Z, Wright M, Freiter E, Robertson F. P1-02-03: The Reciprocal Roles of E-Cadherin and ZEB1 Demonstrate the Mesenchymal-Epithelial Transition as a Primary Characteristic of Inflammatory Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-02-03 |
0.431 |
|
| 2010 |
Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, Krishnamurthy S, Le-Petross H, Bidaut L, Player AN, Barsky SH, Woodward WA, Buchholz T, Lucci A, Ueno NT, et al. Inflammatory breast cancer: the disease, the biology, the treatment. Ca: a Cancer Journal For Clinicians. 60: 351-75. PMID 20959401 DOI: 10.3322/Caac.20082 |
0.335 |
|
| 2010 |
Robertson FM, Ogasawara MA, Ye Z, Chu K, Pickei R, Debeb BG, Woodward WA, Hittelman WN, Cristofanilli M, Barsky SH. Imaging and analysis of 3D tumor spheroids enriched for a cancer stem cell phenotype. Journal of Biomolecular Screening. 15: 820-9. PMID 20639504 DOI: 10.1177/1087057110376541 |
0.384 |
|
| 2010 |
Debeb BG, Zhang X, Krishnamurthy S, Gao H, Cohen E, Li L, Rodriguez AA, Landis MD, Lucci A, Ueno NT, Robertson F, Xu W, Lacerda L, Buchholz TA, Cristofanilli M, et al. Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Molecular Cancer. 9: 180. PMID 20615238 DOI: 10.1186/1476-4598-9-180 |
0.313 |
|
| 2010 |
Robertson FM, Simeone AM, Lucci A, McMurray JS, Ghosh S, Cristofanilli M. Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4. Cancer. 116: 2806-14. PMID 20503412 DOI: 10.1002/Cncr.25167 |
0.403 |
|
| 2010 |
Robertson FM, Woodward WA, Pickei R, Ye Z, Bornmann W, Pal A, Peng Z, Hall CS, Cristofanilli M. Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids. Cancer. 116: 2760-7. PMID 20503408 DOI: 10.1002/Cncr.25176 |
0.432 |
|
| 2010 |
Thudi NK, Mandal PK, McMurray JS, Robertson FM. Abstract 653: Stat3 as a molecular signature and therapeutic target for inflammatory breast cancer Cancer Research. 70: 653-653. DOI: 10.1158/1538-7445.Am10-653 |
0.441 |
|
| 2010 |
Mandal PK, Liao WS, Gao F, Robertson FM, Thudi NK, Ekmekcioglu S, Chattopadhyay C, Ren Z, Chen X, Lu Z, Bast RC, Ramesh R, McMurray JS. Abstract 2527: Potent, highly selective peptidomimetic prodrugs targeting the SH2 domain of Stat3 decrease vasculogenic mimicry, invasion, and anchorage independent growth of cancer cells Cancer Research. 70: 2527-2527. DOI: 10.1158/1538-7445.Am10-2527 |
0.381 |
|
| 2010 |
Chu K, Player AN, Pickei R, Robertson FM. Abstract 1465: Histone deacetylase inhibitor suberoylanilide hydroxamic acid blocks epithelial-mesenchymal transition exhibited by Tera-2 embryonal carcinoma cells with a stem cell phenotype Cancer Research. 70: 1465-1465. DOI: 10.1158/1538-7445.Am10-1465 |
0.412 |
|
| 2010 |
Robertson F, Player A, Chu K, Pickei R, Ye Z, Krishnamurthy S, Liu C, Liu X, Cristofanilli M, Barsky S. Abstract P6-04-13: Gene and microRNA Signatures of the Mesenchymal Epithelial Transition in Pre-Clinical Models of Inflammatory Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P6-04-13 |
0.439 |
|
| 2010 |
Debeb B, Xu W, Lacerda L, Hortobagyi G, Robertson F, Ueno N, Lucci A, Reuben J, Buchholz T, Woodward W. Abstract P4-04-05: Histone Deacetylase Inhibitors Increase Markers of the Dedifferentiated Cancer Stem Cell Phenotype in Human Breast Cancer Cells Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P4-04-05 |
0.35 |
|
| 2009 |
Tanaka T, Decuzzi P, Cristofanilli M, Sakamoto JH, Tasciotti E, Robertson FM, Ferrari M. Nanotechnology for breast cancer therapy. Biomedical Microdevices. 11: 49-63. PMID 18663578 DOI: 10.1007/S10544-008-9209-0 |
0.341 |
|
| 2009 |
Tasciotti E, Bhavane R, Godin-Vilentchouk B, Serda R, Liu X, Robertson F, Ferrari M. A multistage nanodelivery system for therapeutic applications and medical imaging: in vivo biodistribution and efficacy study in a murine orthotopic breast cancer model. Cancer Research. 69: 2160. DOI: 10.1158/0008-5472.Sabcs-2160 |
0.331 |
|
| 2009 |
Robertson F, Simeone A, Lucci A, Woodward W, Reuben J, Ueno N, Cristofanilli M. Role of the prostaglandin receptor EP3 in regulating vasculogenic mimicry of inflammatory breast cancer. Cancer Research. 69: 2127. DOI: 10.1158/0008-5472.Sabcs-2127 |
0.454 |
|
| 2009 |
Ueno N, Kazansky A, LaFortune T, Lucci A, Krishnamurthy S, Hung M, Hortobagyi G, Woodward W, Reuben J, Robertson F, Cristofanilli M, Zhang D. Suppression of mesenchymal phenotype in inflammatory breast cancer by EGFR tyrosine kinase inhibitor erlotinib: a novel approach to suppressing metastasis. Cancer Research. 69: 2042. DOI: 10.1158/0008-5472.Sabcs-2042 |
0.345 |
|
| 2009 |
Hall C, Debeb B, Xu W, Ueno N, Reuben J, Robertson F, Lucci A, Buchholz T, Hortobagyi G, Cristofanilli M, Woodward W. Novel inflammatory breast cancer cell line, MDA-IBC-1 expresses and secretes WISP3, a putative tumor suppressor in inflammatory breast cancer. Cancer Research. 69: 1051. DOI: 10.1158/0008-5472.Sabcs-1051 |
0.402 |
|
| 2009 |
Li C, Lee B, Woodward W, Ueno N, Robertson F, Reuben J, Cristofanilli M. p53 Mutation in Inflammatory Breast Cancer Cell Lines. Cancer Research. 69: 3161-3161. DOI: 10.1158/0008-5472.Sabcs-09-3161 |
0.383 |
|
| 2009 |
Robertson F, Woodward W, Bornmann W, Player A, Ye Z, Cristofanilli M. The pan-HDAC Inhibitor Suberoylanilide Hydroxamic Acid Targets Self Renewal of Breast Cancer Stem Cells. Cancer Research. 69: 3141-3141. DOI: 10.1158/0008-5472.Sabcs-09-3141 |
0.436 |
|
| 2008 |
Robertson FM, Simeone AM, Mazumdar A, Shah AH, McMurray JS, Ghosh S, Cristofanilli M. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells. Journal of Experimental Therapeutics & Oncology. 7: 299-312. PMID 19227010 |
0.305 |
|
| 2007 |
Robertson FM, Mallery SR, Bergdall-Costell VK, Cheng M, Pei P, Prosperi JR, Ferrari M. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts. Anticancer Research. 27: 719-27. PMID 17465194 |
0.316 |
|
| 2006 |
Prosperi JR, Robertson FM. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells. Prostaglandins & Other Lipid Mediators. 81: 55-70. PMID 16997132 DOI: 10.1016/J.Prostaglandins.2006.07.003 |
0.456 |
|
| 2006 |
Robertson FM, Ming-Cheng Cheng M, Prosperi JR, Gaspari M, Terracciano R, Green-Church KB, Vandre DD, Cuda G, Ferrari M. Nanochips for mining the serum and tumor proteome: novel nanochips for sensitive and reproducible identification of the low molecular weight proteome in serum isolated from mice bearing highly invasive human breast tumor xenografts Nanomedicine: Nanotechnology, Biology and Medicine. 2: 295. DOI: 10.1016/J.Nano.2006.10.084 |
0.365 |
|
| 2004 |
Prosperi JR, Mallery SR, Kigerl KA, Erfurt AA, Robertson FM. Invasive and angiogenic phenotype of MCF-7 human breast tumor cells expressing human cyclooxygenase-2. Prostaglandins & Other Lipid Mediators. 73: 249-64. PMID 15290792 DOI: 10.1016/J.Prostaglandins.2004.03.004 |
0.43 |
|
| 2004 |
Mallery SR, Pei P, Landwehr DJ, Clark CM, Bradburn JE, Ness GM, Robertson FM. Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma. Carcinogenesis. 25: 597-603. PMID 14656937 DOI: 10.1093/Carcin/Bgh042 |
0.341 |
|
| 2003 |
Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, Renner RJ, Schuller DE, Robertson FM. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion. Journal of Cellular Biochemistry. 89: 133-43. PMID 12682914 DOI: 10.1002/Jcb.10489 |
0.394 |
|
| 2002 |
Wilgus TA, Parrett ML, Ross MS, Tober KL, Robertson FM, Oberyszyn TM. Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor. Advances in Experimental Medicine and Biology. 507: 85-92. PMID 12664569 DOI: 10.1007/978-1-4615-0193-0_14 |
0.749 |
|
| 2001 |
Oberyszyn TM, Robertson FM, Tober KL, Ross MS, Parrett ML, Wilgus TA, Iyer S, Woo J, Buelow R. Inhibition of cutaneous UV light-induced tumor necrosis factor-alpha protein production by Allotrap 1258, a novel immunomodulatory peptide. Photochemistry and Photobiology. 73: 184-90. PMID 11272733 DOI: 10.1562/0031-8655(2001)073<0184:Ioculi>2.0.Co;2 |
0.734 |
|
| 1999 |
Parrett ML, Abou-Issa HM, Alshafie G, Ross MS, Harris RE, Robertson FM. Comparative ability of ibuprofen and N-(4-hydroxyphenyl)retinamide to inhibit development of rat mammary adenocarcinomas associated with differential inhibition of gene expression of cyclooxygenase isoforms. Anticancer Research. 19: 5079-85. PMID 10697514 |
0.785 |
|
| 1999 |
Alshafie GA, Harris RE, Robertson FM, Parrett ML, Ross M, Abou-Issa H. Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas. Anticancer Research. 19: 3031-6. PMID 10652588 |
0.766 |
|
| 1999 |
Harris RE, Robertson FM, Abou-Issa HM, Farrar WB, Brueggemeier R. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer. Medical Hypotheses. 52: 291-2. PMID 10465664 DOI: 10.1054/Mehy.1998.0009 |
0.461 |
|
| 1999 |
Brueggemeier RW, Quinn AL, Parrett ML, Joarder FS, Harris RE, Robertson FM. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Letters. 140: 27-35. PMID 10403538 DOI: 10.1016/S0304-3835(99)00050-6 |
0.763 |
|
| 1998 |
Tober KL, Cannon RE, Spalding JW, Oberyszyn TM, Parrett ML, Rackoff AI, Oberyszyn AS, Tennant RW, Robertson FM. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice. Biochemical and Biophysical Research Communications. 247: 644-53. PMID 9647747 DOI: 10.1006/Bbrc.1998.8787 |
0.725 |
|
| 1998 |
Oberyszyn TM, Tober KL, Ross MS, Robertson FM. Inhibitory effects of pentoxifylline on ultraviolet B light-induced cutaneous inflammation. Molecular Carcinogenesis. 22: 16-25. PMID 9609097 DOI: 10.1002/(Sici)1098-2744(199805)22:1<16::Aid-Mc3>3.0.Co;2-J |
0.714 |
|
| 1998 |
Oberyszyn TM, Conti CJ, Ross MS, Oberyszyn AS, Tober KL, Rackoff AI, Robertson FM. Beta2 integrin/ICAM-1 adhesion molecule interactions in cutaneous inflammation and tumor promotion. Carcinogenesis. 19: 445-55. PMID 9525279 DOI: 10.1093/Carcin/19.3.445 |
0.69 |
|
| 1998 |
Robertson FM, Parrett ML, Joarder FS, Ross M, Abou-Issa HM, Alshafie G, Harris RE. Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Letters. 122: 165-75. PMID 9464506 DOI: 10.1016/S0304-3835(97)00387-X |
0.77 |
|
| 1997 |
Joarder FS, Abou-Issa H, Robertson FM, Parrett ML, Alshafie G, Harris RE. Growth arrest of DMBA-induced mammary carcinogenesis with ibuprofen treatment in female Sprague-Dawley rats Oncology Reports. 4: 1271-1273. DOI: 10.3892/Or.4.6.1271 |
0.772 |
|
| 1997 |
Parkett ML, Harris RE, Joarder FS, Ross MS, Clausen KP, Robertson FM. Cyclooxygenase-2 gene expression in human breast cancer International Journal of Oncology. 10: 503-507. DOI: 10.3892/Ijo.10.3.503 |
0.458 |
|
| 1996 |
Ariza ME, Oberyszyn AS, Robertson FM, Williams MV. Mutagenic potential of peripheral blood leukocytes: in vivo exposure to the carcinogen 7,12-dimethylbenz[a]anthracene, and the tumor promoter 12-O-tetradecanoylphorbol acetate followed by in vitro co-culture with AS52 cells. Cancer Letters. 106: 9-16. PMID 8827041 DOI: 10.1016/0304-3835(96)04290-5 |
0.343 |
|
| 1996 |
Robertson FM, Long BW, Tober KL, Ross MS, Oberyszyn TM. Gene expression and cellular sources of inducible nitric oxide synthase during tumor promotion. Carcinogenesis. 17: 2053-9. PMID 8824534 DOI: 10.1093/Carcin/17.9.2053 |
0.721 |
|
| 1996 |
Robertson FM, Ross MS, Tober KL, Long BW, Oberyszyn TM. Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline. Carcinogenesis. 17: 1719-28. PMID 8761432 DOI: 10.1093/Carcin/17.8.1719 |
0.73 |
|
| 1996 |
Choban PS, Mcknight T, Flancbaum L, Sabourin CL, Bijur GN, Boros LG, Marley J, Burge JC, Robertson FM. Characterization of a murine model of acute lung injury (ALI): a prominent role for interleukin-1. Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research. 9: 95-109. PMID 8725550 DOI: 10.3109/08941939609012463 |
0.317 |
|
| 1996 |
Wang QS, Sabourin CL, Bijur GN, Robertson FM, Stoner GD. Alterations in transforming growth factor-alpha and epidermal growth factor receptor expression during rat esophageal tumorigenesis. Molecular Carcinogenesis. 15: 144-53. PMID 8599581 DOI: 10.1002/(Sici)1098-2744(199602)15:2<144::Aid-Mc7>3.0.Co;2-J |
0.347 |
|
| 1995 |
Robertson FM, Pellegrini AE, Ross MS, Oberyszyn AS, Boros LG, Bijur GN, Sabourin CL, Oberyszyn TM. Interleukin-1alpha gene expression during wound healing. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 3: 473-84. PMID 17147659 DOI: 10.1046/J.1524-475X.1995.30412.X |
0.348 |
|
| 1995 |
Nill MR, Oberyszyn TM, Ross MS, Oberyszyn AS, Robertson FM. Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/HeN endotoxin-sensitive and C3H/HeJ endotoxin-resistant mice. Journal of Leukocyte Biology. 58: 563-74. PMID 7595058 DOI: 10.1002/Jlb.58.5.563 |
0.345 |
|
| 1994 |
Robertson FM, Bijur GN, Oberyszyn AS, Pellegrini AE, Boros LG, Sabourin CL, Oberyszyn TM. Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion. Carcinogenesis. 15: 1017-29. PMID 8200063 DOI: 10.1093/Carcin/15.5.1017 |
0.437 |
|
| 1993 |
Oberyszyn TM, Sabourin CL, Bijur GN, Oberyszyn AS, Boros LG, Robertson FM. Interleukin-1 alpha gene expression and localization of interleukin-1 alpha protein during tumor promotion. Molecular Carcinogenesis. 7: 238-48. PMID 8352883 DOI: 10.1002/Mc.2940070406 |
0.338 |
|
| Show low-probability matches. |